from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2904c/rplS

LFCtreatmentdescriptionclass of inhibitor

1.688

Amikacinug/mL Amikacintranslation

2.444

Cap5-10ug/mL Capreomycintranslation

3.052

Rox10-50 ug/mL Roxithromycintranslation

0.931

SM2-5 ug/mL Streptomycintranslation

2.587

Tet5-10 ug/mL Tetracyclinetranslation

-0.431

Rif0.2-5ug/mL Rifampicintranscription

-0.497

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.549

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.260

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.502

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.602

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.134

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.571

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-3.070

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.131

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.075

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.592

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.700

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.568

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.169

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.831

KCN5-20 ug/mL Potassium cyaniderespiration

-0.616

NaN30.2-2 mM Sodium aziderespiration

0.633

Nigericin50 uM Nigericinrespiration

-1.327

TRC10-150 ug/mL Triclosanrespiration

-1.018

TRZ10-25 ug/mL Thioridazinerespiration

1.076

Valinomycin0.5-10 uM Valinomycinrespiration

0.081

ZnSO42 mM ZnSO4respiration

0.588

menadione6-10 ug/mL Menadionerespiration

0.047

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.184

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.051

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.007

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.029

NRP_1Non-replicating persistence stage 1dosRassociated

0.566

Amp0.2mg/mL AmpicillincellWall

-0.095

Cephalexin20-100 ug/mL CephalexincellWall

0.681

Cerulenin0.32-5 ug/mL CerulenincellWall

0.506

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.445

EMB10-20 ug/mL EthambutolcellWall

0.570

Eta12-40 ug/mL EthionamidecellWall

0.990

INH0.2-0.4 ug/mL IsoniazidcellWall

0.170

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.425

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.154

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.565

BZA0.12 mg/mL BenzamidearomaticAmides

-0.097

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.006

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.019

H2O24 mM hydrogen peroxideDNAdamaging

0.327

Levo10 ug/mL LevofloxacinDNAdamaging

0.526

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.752

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.290

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.748

UVUV-irradiationDNAdamaging

-0.280

ARP41-4 ug/mL Antitubercular compound ARP4?

0.158

Antimycin12.5-50 ug/mL Antimycin A?

0.009

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.283

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.354

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.351

PA8240.2-2 ug/mL PA-824?

-0.798

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.010

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.020

Verapamil50 uM Verapamil?

-0.232

mercaptoethanol2 mM 2-Mercaptoethanol?

0.145

methoxatin10-20 ug/mL Methoxatin?